Mid Atlantic Bio Angels

About Mid Atlantic Bio Angels

This author has not yet filled in any details.
So far Mid Atlantic Bio Angels has created 50 blog entries.

MABA Portfolio Company FEMSelect Unveils Positive Study Results for Its EnPlace Pelvic Organ Prolapse Repair System

In a recently published article in the International Journal of Gynecology & Obstetrics (IJGO), FEMSelect announced positive results for their EnPlace system. The research was presented during the 2023 International Urogynecology Association 48th Annual Meeting in The Hague, Netherlands. FEMSelect’s EnPlace system offers a new, minimally invasive technique for addressing pelvic organ prolapse without the need for extensive surgery or mesh.

The study titled The EnPlace® sacrospinous ligament fixation—A novel minimally invasive transvaginal procedure for apical pelvic organ prolapse repair: Safety and short-term outcome results, focused on the safety and efficacy of the EnPlace system, a device cleared by the FDA [ Read more… ]

2023-08-29T19:30:18+00:00August 29th, 2023|

MABA Portfolio Company Astrocyte Pharmaceuticals Raises $6M Pre-Series B Financing Round

Alzheimer’s Drug Discovery Foundation Joins Astrocyte Pharmaceuticals’ $6M Pre-Series B Financing Round to Expand Development of Cerebroprotectant AST-004

August 18, 2023 12:39 PM Eastern Daylight Time

GROTON, Conn.–(BUSINESS WIRE)–Astrocyte Pharmaceuticals Inc., a clinical-stage drug discovery and development company advancing novel cerebroprotective therapeutics for patients with brain injuries, announced an oversubscribed pre-Series B Bridge financing round of over $6M that was led by Dreavent Capital, and joined by the Alzheimer’s Drug Discovery Foundation, and other investors. The funding will accelerate the clinical development of AST-004, a highly promising therapeutic candidate aimed at treating a broad array of acute brain injuries including stroke and [ Read more… ]

2023-08-29T19:27:52+00:00August 26th, 2023|